1. Home
  2. CRKN vs SONN Comparison

CRKN vs SONN Comparison

Compare CRKN & SONN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRKN
  • SONN
  • Stock Information
  • Founded
  • CRKN 2015
  • SONN N/A
  • Country
  • CRKN United States
  • SONN United States
  • Employees
  • CRKN N/A
  • SONN N/A
  • Industry
  • CRKN Industrial Machinery/Components
  • SONN Biotechnology: Pharmaceutical Preparations
  • Sector
  • CRKN Technology
  • SONN Health Care
  • Exchange
  • CRKN Nasdaq
  • SONN Nasdaq
  • Market Cap
  • CRKN 2.6M
  • SONN 2.5M
  • IPO Year
  • CRKN N/A
  • SONN N/A
  • Fundamental
  • Price
  • CRKN $6.56
  • SONN $1.65
  • Analyst Decision
  • CRKN
  • SONN Strong Buy
  • Analyst Count
  • CRKN 0
  • SONN 2
  • Target Price
  • CRKN N/A
  • SONN $38.00
  • AVG Volume (30 Days)
  • CRKN 820.1K
  • SONN 282.7K
  • Earning Date
  • CRKN 11-14-2024
  • SONN 02-12-2025
  • Dividend Yield
  • CRKN N/A
  • SONN N/A
  • EPS Growth
  • CRKN N/A
  • SONN N/A
  • EPS
  • CRKN N/A
  • SONN N/A
  • Revenue
  • CRKN $13,461,000.00
  • SONN $18,626.00
  • Revenue This Year
  • CRKN N/A
  • SONN N/A
  • Revenue Next Year
  • CRKN N/A
  • SONN N/A
  • P/E Ratio
  • CRKN N/A
  • SONN N/A
  • Revenue Growth
  • CRKN 22715.25
  • SONN N/A
  • 52 Week Low
  • CRKN $5.51
  • SONN $1.41
  • 52 Week High
  • CRKN $13,500.00
  • SONN $18.72
  • Technical
  • Relative Strength Index (RSI)
  • CRKN 23.88
  • SONN 42.80
  • Support Level
  • CRKN $5.51
  • SONN $1.53
  • Resistance Level
  • CRKN $7.50
  • SONN $1.65
  • Average True Range (ATR)
  • CRKN 3.01
  • SONN 0.17
  • MACD
  • CRKN 1.00
  • SONN 0.02
  • Stochastic Oscillator
  • CRKN 5.28
  • SONN 22.95

About CRKN Crown Electrokinetics Corp.

Crown ElectroKinetics Corp is a provider of DynamicTint. The company's technology allows any glass surface to transition between clear and dark in seconds. DynamicTint allows windows to transition from transparent to black. With applications to a wide array of windows, including commercial buildings, automotive sunroofs, and residential skylights, Crown partners with glass and film manufacturers for mass production and distribution. Its technology is a thin film that is powered by an electrically-charged pigment which not only replaces common window tints but is also a more sustainable alternative to traditional window treatments. It is supported by a robust patent portfolio.

About SONN Sonnet BioTherapeutics Holdings Inc.

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.

Share on Social Networks: